SK

Sheetal Kanodia

Active Director Designated Partner DIN 10489803
DIN 10489803 First appointment Feb 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sheetal Kanodia

Data last updated:

Sheetal Kanodia is a Designated Partner at Medixir Pharmaceutical Distributors Llp (since 2024).

DIN 10489803
Primary Designation Designated Partner
First Appointment 02 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Feb 20242024Active

Board colleagues of Sheetal Kanodia

NameDINCompanyDesignation
Naveen Kanodia10489804Medixir Pharmaceutical Distributors LlpDesignated Partner
Shashankh Kanodia10489805Medixir Pharmaceutical Distributors LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medixir Pharmaceutical Distributors Llp
Premium access

Shareholding and investment profile for Sheetal Kanodia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheetal Kanodia

Sheetal Kanodia currently holds 1 directorship: Medixir Pharmaceutical Distributors Llp (Designated Partner, since 02 Feb 2024).

Sheetal Kanodia was first appointed on 02 Feb 2024 as Designated Partner at Medixir Pharmaceutical Distributors Llp.

The current boards of Sheetal Kanodia's companies include Naveen Kanodia (Medixir Pharmaceutical Distributors Llp), Shashankh Kanodia (Medixir Pharmaceutical Distributors Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available